
Dutch Startup Develops Highly Sensitive Field Test For Infectious Diseases
As climate change accelerates, infectious diseases are becoming more widespread and their toll is is increasing. Efforts like those of Spotlight Diagnostics aimed at developing new and affordable diagnostic tests will go a long way in helping to address the growing prevalence of these diseases. Disease detection is one thing and treatment is another. This is where firms like Soligenix Inc. (NASDAQ: SNGX) come in. These firms are also focusing on...
Read More>>
About BioMedWire
BioMedWire (“BMW”) is a specialized communications platform with a focus on the latest developments in the Biotechnology (BioTech), Biomedical Sciences (BioMed) and Life Sciences sectors. It is one of 70+ brands within the Dynamic Brand Portfolio @ IBN that delivers : (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries ; (2) article and editorial syndication to 5,000+ outlets ; (3) enhanced press release enhancement to ensure maximum impact ; (4) social media distribution via IBN to millions of social media followers ; and (5) a full array of tailored corporate communications solutions . With broad reach and a seasoned team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today's market, BMW brings its clients unparalleled recognition and brand awareness.
BMW is where breaking news, insightful content and actionable information converge.
To receive SMS alerts from BioMedWire,“Biotech” to 888-902-4192 (U.S. Mobile Phones Only)
For more information, please visit
Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: /Disclaimer
BioMedWire
San Francisco, CA
415.949.5050 Office
[email protected]
BioMedWire is powered by IBN
Legal Disclaimer:
MENAFN provides the
information “as is” without warranty of any kind. We do not accept
any responsibility or liability for the accuracy, content, images,
videos, licenses, completeness, legality, or reliability of the information
contained in this article. If you have any complaints or copyright
issues related to this article, kindly contact the provider above.
Most popular stories
Market Research

- Mutuum Finance (MUTM) New Crypto Coin Eyes Next Price Increase As Phase 6 Reaches 50% Sold
- Bydfi Highlights 'BUIDL' Ethos During Newcastle United Match Against Arsenal
- Flexm Recognized As“Highly Commended” In The Regtech Category At The Asia Fintech Awards Singapore 2025
- Solotto Launches As Solana's First-Ever Community-Powered On-Chain Lottery
- Moonx: The Leading Crypto Trading Platform With X1000 Leverage And Unlimited Meme Coin Access
- Stonehaven Circle Marks 13Th Anniversary With Hadrian Colwyn Leading Calvio Ailegacyx Innovation
Comments
No comment